格隆汇3月3日丨华东医药(000963.SZ)近日接受机构调研，就“消费者去香港打少女针的话，这块收入如何计算？”时表示，公司Ellansé产品在香港的销售推广是由第三方经销商代理，因此，正规Ellansé产品在香港地区的收入归属于公司英国全资子公司Sinclair。
另外，就“公司医美未来2-3年内会在国内上市的产品有哪些？”时表示，今年，公司引进爱尔兰EMA公司的面部皮肤管理设备Préime DermaFacial有望在中国上市，医美全资子公司Viora公司的Reaction也将重新登陆中国市场，公司已组建专职销售推广团队，并制定了各个产品的整体市场定位及市场推广计划。
另外，公司正在积极推进Cooltech Define、V系列产品(V20、V30)、Primelase等身体塑形以及脱毛类的医美能量源器械产品的国内注册，将在2024年底陆续上市，MaiLi、伊妍仕M型以及Lanluma等注射类产品正在进行国内临床试验，预计将在2025年上市，其中Lanluma已经先行获批落地海南博鳌乐城，公司也将积极推动更多国外高端创新医美产品引入海南博鳌乐城国际医疗旅游先行区，让中国消费者不出国门就能同步体验全球最新产品。
Gelonghui March 3rd 丨Huadong Pharmaceutical (000963.SZ) was recently surveyed by the agency. “If consumers go to Hong Kong to get injections for young girls, how is this income calculated?” According to the time, the company EllanséThe sale and promotion of products in Hong Kong is represented by a third party dealer, so the official EllanséThe product's revenue in the Hong Kong region goes to Sinclair, a wholly-owned subsidiary of the company in the UK.
Also, as for “what products will the company Medical and Aesthetic be listed domestically in the next 2-3 years?” Shi said that this year, the company introduced the Irish EMA's facial skin care device Préime Dermafacial, which is expected to be listed in China, and Reaction of Viora, a wholly-owned medical and aesthetic subsidiary, will also re-enter the Chinese market. The company has set up a dedicated sales promotion team and formulated an overall market positioning and marketing plan for each product.
In addition, the company is actively promoting the domestic registration of Cooltech Define, V series products (V20, V30), Primelase and other medical and aesthetic energy source products for body shaping and hair removal. They will be launched one after another by the end of 2024. Injectable products such as Maili, Yiyanshi M, and Lanluma are undergoing domestic clinical trials and are expected to be marketed in 2025. Among them, Lanluma has already been approved to land in Lecheng, Hainan. The company will also actively promote the introduction of more high-end innovative medical and aesthetic products from abroad into Boao Le, Hainan The city's international medical tourism pilot zone allows Chinese consumers to simultaneously experience the world's latest products without going abroad.
